Bryant Fong, Director at Neos Therapeutics, Inc. (NEOS), bought 1,500 shares at $6.54 ($10K) on 2016-08-31, disclosed to the SEC on 2016-08-31.
Open-market purchase of $10k NEOS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.